Officials at the Food and Drug Administration (FDA) are currently preparing to release standards for the review and approval of biosimilars, which may soon reach patients in the U.S.
The FDA has not yet provided guidelines to allow for biosimilar entry, putting the benefits to patients and savings of these drugs on hold.
Medicaid operates in a world without economic logic.
No woman was denied “access” to contraception by the recent Supreme Court decision.
The asbestos industry has been able to bamboozle Congress to draft legislation that reduces liability, accountability, and transparency.
African-American women are less likely than white women to be diagnosed with breast cancer, yet they have a higher breast cancer death rate.
Some animal drug compounding pharmacies go far beyond FDA parameters – with deadly results.
Healthcare in rural America depends on the federal government as a reliable business partner.
Hobby is an insult to women and a threat to the religious liberty of women workers.
Classifying Medicare hospital patients as “outpatients,” on Observation Status, means they lose coverage for medically necessary post-hospital nursing home care.